ArticleCureus2023
Comparison of Intra-articular Steroid and Platelet-Rich Plasma Injections in Patients With Knee Osteoarthritis.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThis study aimed to compare the effects of intra-articular steroid (IAS) and platelet-rich plasma (PRP) injections on femoral cartilage thickness and quality of life in patients with knee osteoarthritis (OA).
methodsThis research was designed as a retrospective study with propensity score matching and included 80 treatment-naive patients with knee OA. All patients' demographic characteristics and Visual Analog Scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and Short Form-36 (SF-36) scores before treatment, one month after treatment, and six months after treatment were recorded. Femoral cartilage thickness measurements were taken with ultrasonography. To determine the efficiency of IAS and PRP injections, data was collected before treatment, one month after treatment, and six months after treatment and then compared.
resultsAll VAS values and WOMAC scores were significantly better one month and six months after treatment in both the IAS group and PRP group. However, IAS treatment was associated with significantly lower VAS scores during the night and during movement one month after treatment (p=0.044 and p=0.042). VAS at rest and the WOMAC scores one month after treatment were similar (p=0.435 and p=0.616). All VAS scores (night, rest, and movement) and WOMAC scores were comparable between groups six months after treatment (p=0.569, p=0.504, p=0.584, and p=0.441). There were no significant differences in femoral thickness at the eight measurement points between the groups at the follow-ups.
conclusionOur findings have shown that IAS and PRP injection treatments have a significantly positive effect on the pain and quality of life of patients with knee OA, although this positive effect for pain was significantly better for IAS at night and during movement at the one-month follow-up. Additionally, IAS and PRP injections had positive and comparable healing impacts on femoral cartilage thickness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.